LouisMAledortMD

Professor of Medicine, Mount Sinai School of Medicine

Dr. Aledort is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1190 5th Ave
# Mount
New York, NY 10029
Phone+1 212-241-6756

Fax+1 212-423-0522

Cooperative Study of Factor VIII Inhibitors Start of enrollment: 1978 Jul 01
Completed
Phase 3

PubMed

183 citations
Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A
R S Schwartz, C F Abildgaard, L M Aledort, S Arkin, A L Bloom
The New England Journal of Medicine. 1990-12-27
602 citations
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
David J. Kuter, James B. Bussel, Roger M. Lyons, Vinod Pullarkat, Terry Gernsheimer
Lancet. 2008-02-02
1156 citations
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
James N. George, Steven H. Woolf, Gary E. Raskob, Jeffrey S. Wasser, Louis M. Aledort
Blood. 1996-07-01

Journal Articles

Research Paper Application of Phospho-CyTOF to Characterize Immune Activation in Patients with Sickle Cell Disease in an Ex Vivo Model of Thrombosis
Louis Aledort, MD, ScienceDirect

Hemophilia Drug Hemlibra: Adverse Events Reports and Patient Deaths Raise Some ConcernsDecember 10th, 2019

Safety And Clinical Efficacy Of Recombinant DNA Derived Factor VIIINational Center For Research Resources1993–1994
Intranasal Ddavp Spray In Mild Hemophilia And Von Willebrand'S DiseaseNational Center For Research Resources1992
Safety &Clinical Efficacy Of Recombinant DNA Derived Factor VIIINational Center For Research Resources1990–1992
Recovery And Half-Life Studies Of Factor VII, VIII And IXNational Center For Research Resources1990–1991
IVIG In Treatment Of Autoimmune &Alloimmune Antibodies To Coagulation FactorsNational Center For Research Resources1990–1991
Immunoabsorption For Inhibitors To Factors VIII And IXNational Center For Research Resources1990
Study Of IV Gamma Globulin For Treatment Of Autoimmune/Alloimmune AntibodiesNational Center For Research Resources1989
Immunoabsorption For Inhibitors To Factors VIII And VNational Center For Research Resources1988–1989